Cell-signaling targets for antitumour drug development
- 1 January 1993
- journal article
- review article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 32 (1) , 1-19
- https://doi.org/10.1007/bf00685870
Abstract
No abstract availableThis publication has 148 references indexed in Scilit:
- EGF receptor amplification and expression in human brain tumoursEuropean Journal Of Cancer, 1992
- The cell membrane as a target for cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1991
- The phospholipid analogue, hexadecylphosphocholine, inhibits protein kinase C in vitro and antagonises phorbol ester-stimulated cell proliferationEuropean Journal of Cancer and Clinical Oncology, 1991
- Suramin for prostatic cancer: A phase I/II study in advanced extensively pretreated diseaseEuropean Journal of Cancer and Clinical Oncology, 1990
- Inhibition of phosphatidylinositol-specific phospholipase C by phosphonate substrate analoguesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Permanent conversion of mouse and human cells transformed by activatedras orraf genes to apparently normal cells by treatment with the antibiotic azatyrosineMolecular Carcinogenesis, 1989
- [Leu13-ψ(CH2NH)Leu14]bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cellsBiochemical and Biophysical Research Communications, 1988
- Regulation of protein phosphotyrosine content by changes in tyrosine kinase and protein phosphotyrosine phosphatase activities during induced granulocytic and monocytic differentiation of HL-60 leukemia cellsBiochemical and Biophysical Research Communications, 1986
- Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinaseBiochemical and Biophysical Research Communications, 1986
- Selective cytotoxicity of tumor cells induced by liposomes containing plant phosphatidylinositolBiochemical and Biophysical Research Communications, 1983